Descriptive statistics for responders
| Eylea (n=11) | |
| Central macular thickness on SDOCT (µm), mean (SD) at 12 months | 350.3 (93.3) |
| Central macular thickness on SDOCT (µm), mean (SD) at 6 months | 360.7 (85.2) |
| Change in central macular thickness on SDOCT (µm) from | |
| Baseline to 12 months, mean (SD) | –139.5 (65.8) |
| Baseline to 6 months, mean (SD) | –129.1 (125.1) |
| ETDRS BCVA (letters), mean (SD) at 6 months | 67.5 (10.1) |
| ETDRS BCVA (letters), mean (SD) at 12 months | 68.4 (11.8) |
| Change in ETDRS BCVA (letters) from | |
| Baseline to 12 months, mean (SD) | 4.7 (9.5) |
| Baseline to 6 months, mean (SD) | 3.8 (6.8) |
| Macular volume on SDOCT (mm3), mean (SD) at 6 months | 8.5 (0.6) |
| Macular volume on SDOCT (mm3), mean (SD) at 12 months | 8.5 (0.8) |
| Change in macular volume on SDOCT (mm3) from | |
| Baseline to 12 months, mean (SD) | –0.6 (0.6) |
| Baseline to 6 months, mean (SD) | –0.6 (0.6) |
| Retinal sensitivity (dB), mean (SD) at 6 months | 4.93 (4.06) |
| Retinal sensitivity (dB), mean (SD) at 12 months | 4.48 (3.83) |
| Change in retinal sensitivity (dB) from | |
| Baseline to 12 months, mean (SD) | –0.97 (1.92) |
| Baseline to 6 months, mean (SD) | –0.92 (2.03) |
| Total number of injections received over the study period (12 months), median (IQR) | 7 (6,10) |
BCVA, best corrected visual acuity; dB, decibels; SDOCT, spectral domain optical coherence tomography.